. Author manuscript; available in PMC: 2024 Oct 1.

Published in final edited form as: Clin Gastroenterol Hepatol. 2022 Oct 26;21(11):2965–2967.e2. doi: 10.1016/j.cgh.2022.10.017

Table 1:

Patient Characteristics

	LPR− (AET < 6%), n=55	LPR+ (AET ≥ 6%), n=22	P-Value
Age (years)	49.8 (SD 15.8)	49.8 (SD 14.3)	0.99
Female sex	46 (84%)	14 (64%)	0.06
Body mass index (kg/m²)	24.7 (SD 4.1)	28.0 (SD 6.4)	0.01
Esophageal acid exposure time (%)	1.7 (SD 1.6)	13.1 (SD 11.7)	<0.001
GerdQ score	7.2 (SD 3.2), n=54	8.6 (SD 3.5), n=21	0.09
Reflux symptom index score	19.1 (SD 9.2)	20.9 (SD 8.2)	0.43
EHAS Total	33.2 (SD 14.9)	35.0 (SD 12.8)	0.62
EHAS Q1-9 (anxiety domain)	20.5 (SD 10.1)	20.5 (SD 9.5)	0.99
EHAS Q10-15 (hypervigilance domain)	12.7 (SD 5.9)	14.5 (SD 5.6)	0.22
Elevated EHAS score (> 21)	45 (82%)	19 (86%)	0.63

Depicted as mean (SD) for continuous variables or n (%) for categorical variables. EHAS, esophageal hypervigilance and anxiety scale; LPR, laryngopharyngeal reflux